Related references
Note: Only part of the references are listed.Halogen bonding for molecular recognition: new developments in materials and biological sciences
Gilles Berger et al.
CHEMICAL COMMUNICATIONS (2020)
Catalysis with Pnictogen, Chalcogen, and Halogen Bonds
Sebastian Benz et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2018)
The Halogen Bond
Gabriella Cavallo et al.
CHEMICAL REVIEWS (2016)
Structural characterization of P1′-diversified urea-based inhibitors of glutamate carboxypeptidase II
Jiri Pavlicek et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Salt-bridge-π (sb-π) interactions at work: associative interactions of sb-π, π-π and anion-π in Cu(II)-malonate-2-aminopyridine-hexafluoridophosphate ternary system
Monojit Mitra et al.
CRYSTENGCOMM (2013)
Transmembrane anion transport mediated by halogen-bond donors
Andreas Vargas Jentzsch et al.
NATURE COMMUNICATIONS (2012)
Salt bridges: Geometrically specific, designable interactions
Jason E. Donald et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2011)
Bioisosterism of urea-based GCPII inhibitors: Synthesis and structure-activity relationship studies
Haofan Wang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Molecular recognition of halogen-tagged aromatic VOCs at the air-silicon interface
Guglielmo G. Condorelli et al.
CHEMICAL COMMUNICATIONS (2010)
Interactions between Human Glutamate Carboxypeptidase II and Urea-Based Inhibitors: Structural Characterization
Cyril Barinka et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Dysregulation of glutamate carboxypeptidase II in psychiatric disease
Tomas R. Guilarte et al.
SCHIZOPHRENIA RESEARCH (2008)
Expression of glutamate carboxypeptidase II in human brain
P. Sacha et al.
NEUROSCIENCE (2007)
Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats
Tatsuo Yamamoto et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2007)
NAAG peptidase inhibitor increases dialysate NAAG and reduces glutamate, aspartate and GABA levels in the dorsal hippocampus following fluid percussion injury in the rat
C Zhong et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer
Y Kinoshita et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2005)
Glutamate carboxypeptidase II levels in rodent brain using [125I]DCIT quantitative autoradiography
TR Guilarte et al.
NEUROSCIENCE LETTERS (2005)
Radiolabeled small-molecule ligands for prostate-specific membrane antigen:: In vivo imaging in experimental models of prostate cancer
CA Foss et al.
CLINICAL CANCER RESEARCH (2005)
NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats
CL Zhong et al.
JOURNAL OF NEUROTRAUMA (2005)
Synthesis of urea-based inhibitors as active site probes of glutamate carboxypeptidase II: Efficacy as analgesic agents
AP Kozikowski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Antinociceptive effects of N-acetylaspartylglutamate (NAAG) peptidase inhibitors ZJ-11, ZJ-17 and ZJ-43 in the rat formalin test and in the rat neuropathic pain model
T Yamamoto et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
Photodegradation of halobenzenes in water ice
P Klan et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2001)
N-acetylaspartylglutamate:: The most abundant peptide neurotransmitter in the mammalian central nervous system
JH Neale et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Glutamate as a neurotransmitter in the brain: Review of physiology and pathology
BS Meldrum
JOURNAL OF NUTRITION (2000)
Share Paper
